reported an exacerbation of systemic lupus erythematosus in one patient; when the oral contraceptive was withdrawn she remained in remission (Pimstone 1968) . Schleicher (1968) found the L.E.-cell phenomenon in ten apparently healthy young women who were receiving oral contraceptives ; L.E.-cell tests were negative 4-8 weeks after the drugs were withdrawn. The apparent frequency of this finding has been disputed (Dubois et al. 1968 ). The development of rheumatic complaints in one group of women taking oral contraceptives and followed up in a planned-parenthood clinic has been interpreted by Gill (1968) (Friou 1967 
Results

Clinical Findings
Each patient was given a detailed clinical examination dominated, but the nuclear pattern did change when the serum was diluted. Five patients' sera were negative after drug withdrawal. These tests were done on specimens obtained from individual patients 6 weeks to 16 months after stopping oral contraceptives. In two patients who elected to resume drug therapy, one was positive at 2 months (case 7) and the other negative at 8 months (case 6). The patient with systemic lupus erythematosus (case 8) continued to have detectable antinuclear antibodies in her serum 6 months after stopping ovulen. Six patients had positive L.E.-cell tests while on anovulatory drugs (identification of one typical L.E. cell was considered positive). Follow-up sera were negative, except for the patient with systemic lupus erythematosus (S.L.E.), who remained off the drug, and the patient who had resumed oral contraceptives (case 6). Rheumatoid factor was detected in the sera in cases 2 and 8.
Slight increases in IgM levels were found in five of the patients' while on oral contraceptives (table iv). The increase persisted in the two patients who resumed drug therapy (cases 6 and 7) and in two who remained off therapy. The patient with S.L.E. also had increased levels of IgG. Acid-soluble ocl-glycoprotein, &laquo;2 macroglobulin, and transferrin were normal in most cases during and after (Hollander 1966) and systemic lupus erythematosus (Mund et al. 1963) (Rotstein et al. 1962) , and the report of Pimstone (1966) . Gill (1968) has reported that the prevalence (0.66%) of rheumatoid arthritis in women taking oral contraceptives and followed up in a birthcontrol clinic population (84% Negro, 16% White) was no greater than that noted in other population surveys. Indirect comparisons of this type are difficult to interpret. In Gill's (1968) 
